Breast Cancer News and Research

Latest Breast Cancer News and Research

New biomarkers can predict patients' response to certain drugs

Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.

19 Nov 2009

UAB expert recommends research and evidence to interpret new mammography guidelines

The public may have problems this week sorting through news articles about a government task force's opposition to routine mammograms for women under 50 and articles about breast cancer survivors touting the benefits of early mammograms. But to properly interpret the news, the public must learn to balance the research with the anecdotal evidence says University of Alabama at Birmingham (UAB) Associate Professor of English Cynthia Ryan, Ph.D.

19 Nov 2009

Queen’s University Belfast to study individualized radiotherapy treatment for breast cancer

Individualised radiotherapy treatment based on a person’s genetic make up could soon become a reality, according to Breast Cancer Campaign.

19 Nov 2009

Researchers develop new device with nano-sized features to grab cancer cells

Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.

19 Nov 2009

iCAD and AdMeTech Foundation sign a strategic partnership agreement

iCAD, Inc., an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announces a strategic partnership with the AdMeTech Foundation, a non-profit organization with a mission to end prostate cancer as a patient care crisis and socio-economic problem.

19 Nov 2009

Radiation breakthrough to treat breast cancer patients in one day arrives at CTCA

A radiation breakthrough to treat breast cancer patients in one day, as opposed to the current average of six weeks, has arrived at Cancer Treatment Centers of America(R) (CTCA) in Philadelphia. CTCA will become the first in the country to offer this treatment option using the Novac7 technology from Rome, Italy.

19 Nov 2009

Sebelius issues statement on mammography guidelines as GOP attacks health reform proposals

ABC News: "HHS Secretary Sebelius did her best to ride the wave of incredulous opposition to the new government-sponsored guidelines advising women to hold off on regular mammograms til age 50. Perhaps anticipating that opponents of the President's health reform efforts will argue that this is a glimpse of the future under Obamacare."

19 Nov 2009

Tempest over new mammography guidelines affect health legislation, insurance guidelines

Newspapers across the country featured front-page follow-up stories on new mammogram recommendations today.

18 Nov 2009

Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.

18 Nov 2009

Power3 Medical Products launches Phase II trials for Alzheimer's and Parkinson's diseases blood diagnostic tests

BioMedReports.com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has issued a special report on Power3 Medical Products, the developer of several blood tests designed for early detection, monitoring and targeting of diseases like Alzheimer's, Parkinson's and breast cancer.

18 Nov 2009

NBCC: Revised USPSTF guidelines will put screening and its limitations into proper perspective

For over a decade, National Breast Cancer Coalition has held the position that over-emphasis on the importance of breast cancer screening, despite a lack of strong evidence, has been elevated to such a degree that some even equate screening with prevention.

18 Nov 2009

Cancer-fighting protein successfully placed directly into solid tumors and turned on

Experiments at the Pioneer Valley Life Sciences Institute (PVLSI) at Baystate Medical Center in Springfield, Mass., reported in a recent British Journal of Cancer, confirm that University of Massachusetts Amherst chemical engineer Neil Forbes' delivery and trigger system has for the first time successfully placed TRAIL, a cancer-fighting protein, directly into solid tumors and on cue, turned it on. The treatment improved the 30-day survival time of mice with mammary tumors from 0 to 100 percent.

18 Nov 2009

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

IBM (IBM) scientists have created a one-step point-of-care-diagnostic test, based on an innovative silicon chip, that requires less sample volume, is significantly faster, portable, easy to use, and can test for many diseases, including one of world's leading causes of death, cardiovascular disease.

18 Nov 2009

CRESTOR reduces major cardiovascular events in women by 46%

A new analysis of the JUPITER trial, released today at the American Heart Association meeting in Orlando, Florida, demonstrates that CRESTOR (rosuvastatin calcium) 20mg reduced first major cardiovascular events by 46%.

18 Nov 2009

Family caregivers can reduce suffering in cancer patients through simple touch and massage techniques

Family caregivers can significantly reduce suffering in cancer patients at home through use of simple touch and massage techniques. These findings were recently reported at the 6th International Conference of the Society for Integrative Oncology.

18 Nov 2009

GlaxoSmithKline and bioMerieux to develop predictive test for breast cancer treatments

bioMerieux has signed an agreement with GlaxoSmithKline to develop a predictive test to help clinicians select the most appropriate treatment for different segments of breast cancer patients.

17 Nov 2009

Startling new mammogram guidelines incite debate about risk, cost

The Washington Post: "Women in their 40s should stop routinely having annual mammograms and older women should cut back to one scheduled exam every other year, an influential federal task force has concluded, challenging the use of one of the most common medical tests" (Stein, 11/17).

17 Nov 2009

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Professor John F. Thompson, MD, Professor of Melanoma and Surgical Oncology at the University of Sydney, Director of the Melanoma Institute Australia, and Lead Investigator of the Phase 2 study of PV-10 for Metastatic Melanoma, will be presenting data at the 3rd World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November 21, 2009 in Berlin, Germany.

17 Nov 2009

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

To highlight results of more recent research, the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference will host a press briefing on "Drugs in the Pipeline." Sara A. Courtneidge, Ph.D., D.Sc., professor and director of the Tumor Microenvironment Program, and director of academic affairs at the Burnham Institute for Medical Research, will moderate this press briefing.

17 Nov 2009

USPSTF recommendations against regular mammography screening can result in unnecessary breast cancer deaths

If cost-cutting U.S. Preventive Services Task Force (USPSTF) mammography recommendations are adopted as policy, two decades of decline in breast cancer mortality could be reversed and countless American women may die needlessly from breast cancer each year.

17 Nov 2009

Breast Cancer News and Research

Latest Breast Cancer News and Research

New biomarkers can predict patients' response to certain drugs

UAB expert recommends research and evidence to interpret new mammography guidelines

Queen’s University Belfast to study individualized radiotherapy treatment for breast cancer

Researchers develop new device with nano-sized features to grab cancer cells

iCAD and AdMeTech Foundation sign a strategic partnership agreement

Radiation breakthrough to treat breast cancer patients in one day arrives at CTCA

Sebelius issues statement on mammography guidelines as GOP attacks health reform proposals

Tempest over new mammography guidelines affect health legislation, insurance guidelines

Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented

Power3 Medical Products launches Phase II trials for Alzheimer's and Parkinson's diseases blood diagnostic tests

NBCC: Revised USPSTF guidelines will put screening and its limitations into proper perspective

Cancer-fighting protein successfully placed directly into solid tumors and turned on

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

CRESTOR reduces major cardiovascular events in women by 46%

Family caregivers can reduce suffering in cancer patients through simple touch and massage techniques

GlaxoSmithKline and bioMerieux to develop predictive test for breast cancer treatments

Startling new mammogram guidelines incite debate about risk, cost

Melanoma Institute director to present Phase 2 study data of PV-10 for metastatic melanoma

AACR-NCI-EORTC conference highlights major expansion in cancer drug pipeline

USPSTF recommendations against regular mammography screening can result in unnecessary breast cancer deaths

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in